Literature DB >> 3307603

Age-related shrinkage of cortically projecting cholinergic neurons: a selective effect.

M M Mesulam, E J Mufson, J Rogers.   

Abstract

The number and size of basal forebrain neurons that provide the cholinergic innervation for the cerebral cortex, amygdala, and hippocampus were studied in young and aged mice. The results showed that these neurons became substantially smaller with increasing age. This effect was relatively selective, since the immediately adjacent cholinergic neurons in the striatum did not show a change of similar magnitude. The shrinkage of these basal forebrain neurons may account for the decline of cholinergic innervation that occurs with age. In the material that we examined, aging did not influence the number of cholinergic neurons in the basal forebrain, only their size. It seems, therefore, that the age-related changes in cholinergic function (and their putative behavioral consequences) are not associated with a substantial component of irreversible cell death.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307603     DOI: 10.1002/ana.410220109

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

2.  Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.

Authors:  R B Gibbs; A M Chipman; R Hammond; D Nelson
Journal:  Horm Behav       Date:  2011-08-26       Impact factor: 3.587

3.  Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system.

Authors:  Emily M Stanley; Jim Fadel
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

4.  Age-related decline in central cholinergic function demonstrated with scopolamine.

Authors:  P N Tariot; S V Patel; C Cox; R E Henderson
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

5.  Cholinergic aspects of aging and Alzheimer's disease.

Authors:  Marsel Mesulam
Journal:  Biol Psychiatry       Date:  2012-05-01       Impact factor: 13.382

Review 6.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

7.  Muscarinic M1 Receptors Modulate Working Memory Performance and Activity via KCNQ Potassium Channels in the Primate Prefrontal Cortex.

Authors:  Veronica C Galvin; Sheng Tao Yang; Constantinos D Paspalas; Yang Yang; Lu E Jin; Dibyadeep Datta; Yury M Morozov; Taber C Lightbourne; Adam S Lowet; Pasko Rakic; Amy F T Arnsten; Min Wang
Journal:  Neuron       Date:  2020-03-19       Impact factor: 17.173

8.  Compensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment.

Authors:  Nathalie Mandairon; Shane T Peace; Karim Boudadi; Christine E Boxhorn; Venkata Anupama Narla; Sara D Suffis; Thomas A Cleland
Journal:  Neurobiol Aging       Date:  2010-01-15       Impact factor: 4.673

9.  Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis.

Authors:  R B Gibbs; R Mauk; D Nelson; D A Johnson
Journal:  Horm Behav       Date:  2009-03-20       Impact factor: 3.587

Review 10.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.